English
CJC-1295 without DAC and Ipamorelin Peptide Blend combines two distinct peptide components in a single product configuration. CJC-1295 without DAC is distinguished from the DAC-containing form by its product designation, while Ipamorelin is a separate synthetic peptide studied in relation to growth hormone secretion pathways.
For buyers sourcing peptide research materials, the distinction between peptide identity, formulation composition and individual component content is important. A clear product specification helps laboratories and distributors evaluate whether the material matches their documented research requirements.
JinBei supports international procurement with product information, available quality documentation and order coordination. Buyers can confirm the stated composition, batch documentation, packaging configuration and applicable handling requirements before placing an order.
The “without DAC” designation identifies the intended product form and distinguishes it from CJC-1295 formulations containing a Drug Affinity Complex (DAC). Buyers should verify the exact peptide identity and sequence through the product-specific specification and available analytical documentation rather than relying on the product name alone.
Ipamorelin is a synthetic peptide investigated in research involving growth hormone secretory pathways. Its identity and stated content should be documented separately from those of the other component in a two-peptide formulation.
The supplied product description specifies 5mg of CJC-1295 without DAC and 5mg of Ipamorelin. This represents a nominal 1:1 ratio by stated weight, with a combined stated content of 10mg per unit.
The combination should not automatically be described as producing a proven synergistic effect. The biological effects of individual peptides and their combined effects are separate questions that require appropriate supporting evidence.
When comparing blended peptide materials, buyers need more than a product name. Composition, documentation, packaging and handling requirements all contribute to a practical purchasing assessment.
The stated formulation identifies CJC-1295 without DAC and Ipamorelin as separate components, each listed at 5mg.
Available COA documentation can support review of reported analytical results and the applicable batch information.
Packaging configuration, unit quantity and minimum order requirements can be confirmed with JinBei before purchasing.
Product-specific storage and handling conditions should be confirmed using the applicable label and documentation.
CJC-1295 without DAC and Ipamorelin are associated with research into growth hormone secretory pathways. These research interests do not establish that the combined product is an approved treatment or that it produces specific outcomes in humans.
Depending on the study design and applicable approvals, qualified researchers may investigate questions involving peptide identity, analytical characterization, biological signaling or other relevant mechanisms. The appropriate research scope depends on the material's confirmed identity, the experimental model and the applicable regulatory framework.
JinBei's role in the procurement process is to provide relevant product information and available documentation so that buyers can assess material suitability against their own requirements. No specific therapeutic, anti-aging, body-composition or performance outcome should be inferred from the product name alone.
|
Parameter |
Available Information |
|
Product Name |
CJC-1295 without DAC and Ipamorelin Peptide Blend |
|
Brand |
JinBei |
|
Components |
CJC-1295 without DAC and Ipamorelin |
|
Stated Component Content |
5mg + 5mg |
|
Stated Total Content |
10mg per unit, subject to label confirmation |
|
Stated Weight Ratio |
1:1 |
|
Product Form |
To be confirmed |
|
Appearance |
To be confirmed |
|
Purity |
Refer to the applicable product specification and COA |
|
Melting Point |
Original data states above 177°C (decomposition); product-specific applicability requires verification |
|
Density |
Original data states 1.45; material and unit basis require verification |
|
Solubility |
Original data lists limited solubility in ethanol, methanol and water; applicability to the complete blend requires verification |
|
Storage Conditions |
Original data states −20°C under an inert atmosphere; confirm for this specific blend |
|
Shelf Life |
Original FAQ states usually two years; confirm against the product label and supporting documentation |
|
Quality Documentation |
COA available |
This product page is intended for professional audiences evaluating peptide research materials, subject to applicable laws and the intended use.
Research-material procurement teams reviewing product identity, stated composition and supporting documentation.
Qualified laboratory research organizations sourcing peptide materials for authorized research projects.
Specialty chemical and peptide distributors assessing supplier documentation, packaging and purchasing terms.
International raw material traders coordinating product specifications, quotations and export arrangements.
Buyers should establish the intended use and required specifications before placing an order. The product should not be marketed as a proven anti-aging treatment or as an approved therapy for hormonal or metabolic conditions.
The designation indicates the intended form without the Drug Affinity Complex (DAC) associated with DAC-containing CJC-1295 formulations. Buyers should verify the precise identity and sequence of the supplied material using product-specific documentation.
The supplied product description lists 5mg of CJC-1295 without DAC and 5mg of Ipamorelin per unit. The stated total is 10mg, with a nominal 1:1 weight ratio. Please confirm the actual configuration against the product label.
Yes. COA documentation is available. Buyers can request the relevant document to review its reported analytical information, batch details and specifications.
The source FAQ states one box containing 10 vials for certain peptide products, but this packaging has not been independently confirmed for this specific blend. Please contact JinBei to verify the applicable MOQ and quantity per box.
Yes. Sample inquiries are accepted, and samples are chargeable according to the applicable price list. Availability, quantity and shipping costs should be confirmed before ordering.
The original source information states a typical shelf life of two years. The actual shelf life should be verified against the product-specific label and supporting documentation.
The source information states −20°C under an inert atmosphere. Because this condition has not been confirmed for the complete blend, buyers should request the applicable storage and handling instructions before arranging storage.
Factory visits are temporarily unavailable under the current site-visit arrangements. Please contact JinBei to discuss product information and purchasing requirements.
Yes. JinBei has an office in Shanghai, China. Buyers can contact the company regarding product documentation, quotations and order coordination.
JinBei serves customers in multiple international markets, including the United States, the Philippines and Australia. Local agent availability depends on the destination market and current arrangements. Please contact JinBei to confirm.
Address
No. 1599, Pingzhuang West Road, Fengxian District, Shanghai City, China
Tel
